© 2002 American Thoracic Society
Expression of Human Telomerase Reverse Transcriptase in LymphangioleiomyomatosisPathology Section and Pulmonary Critical Care Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland Correspondence and requests for reprints should be addressed to Zu-Xi Yu, M.D., Ph.D., Pathology Section, National Heart, Lung, and Blood Institute, Building 10/2N240, National Institutes of Health, 10 Center Drive MSC-1518, Bethesda, MD 20892-1518. E-mail: yuz{at}helix.nih.gov
Telomerase synthesizes nucleotide hexameric repeats (telomeres) at the ends of chromosomes, replacing base sequences that are lost from these sites during each mitotic cycle and protecting these ends against the action of exonucleases and ligases. Therefore, telomerase is essential for maintaining cellular replication. To evaluate the role of telomerase in the proliferation of abnormal smooth muscle cells (lymphangioleiomyomatosis [LAM] cells) in LAM, we performed immunostaining and in situ hybridization studies to identify telomerase protein and messenger RNA (mRNA), respectively, in pulmonary (n = 18) and extrapulmonary (n = 4) lesions from 22 women with LAM (14 untreated and 8 treated with progesterone or tamoxifen). Immunoreactivity and hybridization signals for telomerase were observed in 5 to 20% of LAM cells, mostly of the spindle-shaped type, in 21 of the 22 patients, and were less intense in the treated group. Other types of cells were unreactive in both groups. Telomerase colocalized in the same cells with
Key Words: lymphangioleiomyomatosis lung telomerase smooth muscle cells This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||